This hypothesis is strongly corroborated by observations in a mouse model where inhibition of the C-Terminal Src Kinase (CSK) by ibrutinib was identified as the causal mechanism of ibrutinib-related AF [41]. This evidence concerns the gene CSK and atrial fibrillation.